Analyst Reco. Embecta Corp.

Equities

EMBC

US29082K1051

Real-time Estimate Cboe BZX Other stock markets 10:35:20 2024-06-10 am EDT			5-day change	1st Jan Change
12.02 ^USD	-3.42%		-6.36%	-36.58%

May. 16	Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09	Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating	Nov. 22	MT
Morgan Stanley Adjusts Price Target on Embecta to $15 From $16, Maintains Underweight Rating	23-10-18	MT
BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating	23-10-18	MT
Morgan Stanley Trims Price Target on Embecta to $16 From $19, Maintains Underweight Rating	23-08-24	MT
Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating	23-07-18	MT
Morgan Stanley Downgrades Embecta to Underweight From Equalweight, Price Target is $28	23-01-06	MT
Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating	22-12-21	MT
Morgan Stanley Adjusts Price Target on Embecta Corp. to $33 From $36, Reiterates Equalweight Rating	22-10-11	MT
BTIG Initiates Embecta at Neutral	22-09-08	MT
Morgan Stanley Adjusts Price Target on Embecta to $36 From $33, Keeps Equalweight Rating	22-08-16	MT
Morgan Stanley Initiates Embecta at Equalweight with $33 Price Target	22-08-01	MT
BofA Securities Initiates Embecta at Underperform with $25 Price Target	22-06-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer